841 related articles for article (PubMed ID: 18836528)
1. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?
Moussion C; Ortega N; Girard JP
PLoS One; 2008 Oct; 3(10):e3331. PubMed ID: 18836528
[TBL] [Abstract][Full Text] [Related]
2. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain.
Pichery M; Mirey E; Mercier P; Lefrancais E; Dujardin A; Ortega N; Girard JP
J Immunol; 2012 Apr; 188(7):3488-95. PubMed ID: 22371395
[TBL] [Abstract][Full Text] [Related]
3. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo.
Carriere V; Roussel L; Ortega N; Lacorre DA; Americh L; Aguilar L; Bouche G; Girard JP
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):282-7. PubMed ID: 17185418
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells.
Pollheimer J; Bodin J; Sundnes O; Edelmann RJ; Skånland SS; Sponheim J; Brox MJ; Sundlisaeter E; Loos T; Vatn M; Kasprzycka M; Wang J; Küchler AM; Taskén K; Haraldsen G; Hol J
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):e47-55. PubMed ID: 23162017
[TBL] [Abstract][Full Text] [Related]
5. IL-33 is regulated by TNF-α in normal and psoriatic skin.
Balato A; Di Caprio R; Canta L; Mattii M; Lembo S; Raimondo A; Schiattarella M; Balato N; Ayala F
Arch Dermatol Res; 2014 Apr; 306(3):299-304. PubMed ID: 24522896
[TBL] [Abstract][Full Text] [Related]
6. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1.
Cayrol C; Girard JP
Proc Natl Acad Sci U S A; 2009 Jun; 106(22):9021-6. PubMed ID: 19439663
[TBL] [Abstract][Full Text] [Related]
7. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
8. Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines.
Chen Z; Colon I; Ortiz N; Callister M; Dong G; Pegram MY; Arosarena O; Strome S; Nicholson JC; Van Waes C
Cancer Res; 1998 Aug; 58(16):3668-76. PubMed ID: 9721877
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-33 and Behçet disease: Another cytokine among others.
Hamzaoui K; Bouali E; Hamzaoui A
Hum Immunol; 2015 May; 76(5):301-6. PubMed ID: 25814446
[TBL] [Abstract][Full Text] [Related]
10. Role of interleukin-33 in innate-type immune cells in allergy.
Nakae S; Morita H; Ohno T; Arae K; Matsumoto K; Saito H
Allergol Int; 2013 Mar; 62(1):13-20. PubMed ID: 23439054
[TBL] [Abstract][Full Text] [Related]
11. Analysis of nuclear localization of interleukin-1 family cytokines by flow cytometry.
Ross R; Grimmel J; Goedicke S; Möbus AM; Bulau AM; Bufler P; Ali S; Martin MU
J Immunol Methods; 2013 Jan; 387(1-2):219-27. PubMed ID: 23159404
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-33 - cytokine of dual function or novel alarmin?
Haraldsen G; Balogh J; Pollheimer J; Sponheim J; Küchler AM
Trends Immunol; 2009 May; 30(5):227-33. PubMed ID: 19359217
[TBL] [Abstract][Full Text] [Related]
13. IL-32: a newly-discovered proinflammatory cytokine.
Felaco P; Castellani ML; De Lutiis MA; Felaco M; Pandolfi F; Salini V; De Amicis D; Vecchiet J; Tete S; Ciampoli C; Conti F; Cerulli G; Caraffa A; Antinolfi P; Cuccurullo C; Perrella A; Theoharides TC; Conti P; Toniato E; Kempuraj D; Shaik YB
J Biol Regul Homeost Agents; 2009; 23(3):141-7. PubMed ID: 19828090
[TBL] [Abstract][Full Text] [Related]
14. IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation.
Balato A; Lembo S; Mattii M; Schiattarella M; Marino R; De Paulis A; Balato N; Ayala F
Exp Dermatol; 2012 Nov; 21(11):892-4. PubMed ID: 23163661
[TBL] [Abstract][Full Text] [Related]
15. Cytokine and adhesion molecule expression in primary human endothelial cells stimulated with fever-range hyperthermia.
Shah A; Unger E; Bain MD; Bruce R; Bodkin J; Ginnetti J; Wang WC; Seon B; Stewart CC; Evans SS
Int J Hyperthermia; 2002; 18(6):534-51. PubMed ID: 12537753
[TBL] [Abstract][Full Text] [Related]
16. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells.
Khayyamian S; Hutloff A; Büchner K; Gräfe M; Henn V; Kroczek RA; Mages HW
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6198-203. PubMed ID: 11983910
[TBL] [Abstract][Full Text] [Related]
17. The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells.
Song KW; Talamas FX; Suttmann RT; Olson PS; Barnett JW; Lee SW; Thompson KD; Jin S; Hekmat-Nejad M; Cai TZ; Manning AM; Hill RJ; Wong BR
Mol Immunol; 2009 Apr; 46(7):1458-66. PubMed ID: 19181383
[TBL] [Abstract][Full Text] [Related]
18. Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation.
Küchler AM; Pollheimer J; Balogh J; Sponheim J; Manley L; Sorensen DR; De Angelis PM; Scott H; Haraldsen G
Am J Pathol; 2008 Oct; 173(4):1229-42. PubMed ID: 18787100
[TBL] [Abstract][Full Text] [Related]
19. Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation.
Ock S; Ahn J; Lee SH; Park H; Son JW; Oh JG; Yang DK; Lee WS; Kim HS; Rho J; Oh GT; Abel ED; Park WJ; Min JK; Kim J
Cardiovasc Res; 2012 Apr; 94(1):105-14. PubMed ID: 22298642
[TBL] [Abstract][Full Text] [Related]
20. Mature interleukin-33 is produced by calpain-mediated cleavage in vivo.
Hayakawa M; Hayakawa H; Matsuyama Y; Tamemoto H; Okazaki H; Tominaga S
Biochem Biophys Res Commun; 2009 Sep; 387(1):218-22. PubMed ID: 19596270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
